FDA Virtual Town Hall for Labs, Manufacturers of Covid-19 Diagnostics
Today the FDA is hosting a virtual Town Hall for clinical labs and manufacturers that are developing or have developed diagnostics for covid-19.
Read MorePosted by Melanie Hamilton-Basich | Aug 31, 2020 | Covid 19 |
Today the FDA is hosting a virtual Town Hall for clinical labs and manufacturers that are developing or have developed diagnostics for covid-19.
Read MorePosted by Melanie Hamilton-Basich | Aug 31, 2020 | Covid 19 |
Researchers developed the alternative, low-cost covid-19 test by leveraging CRISPR-based technology, which has been widely used for gene editing.
Read MorePosted by Laurie Bonner | Aug 30, 2020 | Covid 19, Information Technology |
With the Health Platform smartphone app, a person can show that they’ve received a recent negative result on a covid-19 test.
Read MorePosted by Melanie Hamilton-Basich | Aug 29, 2020 | Covid 19, Molecular Diagnostics |
A mutation in the N gene of SARS-CoV-2 impairs the annealing of a commonly used RT-PCR primer.
Read MorePosted by Melanie Hamilton-Basich | Aug 29, 2020 | Covid 19, Miscellaneous |
The covid-19 crisis has caused limited access to funding, labs, and publishing, jeopardizing the careers of young scientists.
Read More